158 related articles for article (PubMed ID: 34743989)
1. Expression of GALNT8 and O-glycosylation of BMP receptor 1A suppress breast cancer cell proliferation by upregulating ERα levels.
Huang T; Wu Q; Huang H; Zhang C; Wang L; Wang L; Liu Y; Li W; Zhang J; Liu Y
Biochim Biophys Acta Gen Subj; 2022 Jan; 1866(1):130046. PubMed ID: 34743989
[TBL] [Abstract][Full Text] [Related]
2. GALNT8 suppresses breast cancer cell metastasis potential by regulating EGFR O-GalNAcylation.
Huang T; Meng F; Huang H; Wang L; Wang L; Liu Y; Liu Y; Wang J; Li W; Zhang J; Liu Y
Biochem Biophys Res Commun; 2022 Apr; 601():16-23. PubMed ID: 35220009
[TBL] [Abstract][Full Text] [Related]
3. GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A.
Yang Y; Ding M; Yin H; Chen W; Shen H; Diao W; Yang L; Qin H; Gan W; Qiu X; Guo H
Int J Biol Sci; 2024; 20(4):1297-1313. PubMed ID: 38385080
[TBL] [Abstract][Full Text] [Related]
4. GalNAc-T4 putatively modulates the estrogen regulatory network through FOXA1 glycosylation in human breast cancer cells.
Niang B; Jin L; Chen X; Guo X; Zhang H; Wu Q; Padhiar AA; Xiao M; Fang D; Zhang J
Mol Cell Biochem; 2016 Jan; 411(1-2):393-402. PubMed ID: 26541755
[TBL] [Abstract][Full Text] [Related]
5. Induction of estrogen receptor α-36 expression by bone morphogenetic protein 2 in breast cancer cell lines.
Wang D; Huang P; Zhu B; Sun L; Huang Q; Wang J
Mol Med Rep; 2012 Sep; 6(3):591-6. PubMed ID: 22711074
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.
Takahashi M; Otsuka F; Miyoshi T; Otani H; Goto J; Yamashita M; Ogura T; Makino H; Doihara H
J Endocrinol; 2008 Dec; 199(3):445-55. PubMed ID: 18780779
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.
Liu Y; Zhang RX; Yuan W; Chen HQ; Tian DD; Li H; Jiang X; Deng ZL; Wang Y
Cell Physiol Biochem; 2018; 45(5):1759-1771. PubMed ID: 29495003
[TBL] [Abstract][Full Text] [Related]
9. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
[TBL] [Abstract][Full Text] [Related]
10. BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development.
Pan H; Zhang H; Abraham P; Komatsu Y; Lyons K; Kaartinen V; Mishina Y
Dev Biol; 2017 Sep; 429(1):260-270. PubMed ID: 28641928
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.
Pickup MW; Hover LD; Guo Y; Gorska AE; Chytil A; Novitskiy SV; Moses HL; Owens P
Oncotarget; 2015 Sep; 6(26):22890-904. PubMed ID: 26274893
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
13. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
Thaler S; Schmidt M; Schad A; Sleeman JP
Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
16. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
[TBL] [Abstract][Full Text] [Related]
17. Activation of the bone morphogenetic protein receptor by H11kinase/Hsp22 promotes cardiac cell growth and survival.
Sui X; Li D; Qiu H; Gaussin V; Depre C
Circ Res; 2009 Apr; 104(7):887-95. PubMed ID: 19246680
[TBL] [Abstract][Full Text] [Related]
18. Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development.
Edson MA; Nalam RL; Clementi C; Franco HL; Demayo FJ; Lyons KM; Pangas SA; Matzuk MM
Mol Endocrinol; 2010 Jun; 24(6):1251-66. PubMed ID: 20363875
[TBL] [Abstract][Full Text] [Related]
19. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
[TBL] [Abstract][Full Text] [Related]
20. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
